Your SlideShare is downloading. ×
×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

ANGLE plc aims to signs more deals

75

Published on

Andrew Newland, chief executive of Angle plc (LON:AGL), tells Proactiveinvestors that the company is now expanding the market it is targeting for Parsortix, its blood separation technology. Andrew …

Andrew Newland, chief executive of Angle plc (LON:AGL), tells Proactiveinvestors that the company is now expanding the market it is targeting for Parsortix, its blood separation technology. Andrew also says that Angle is 'close' to achieving US Food & Drug Administration (FDA) approval.

Published in: Investor Relations
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
75
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

×